CRISPR Therapeutics Provides Business Update and Reports Second Quarter 2026 Financial Results

FITCH AFFIRMS CHINA CREDIT RATING AT 'A' →

FITCH ISSUES NEW STATEMENT AND OUTLOOK ON U.S . CREDIT RATING DEBT WARNING IN FIRST PARAGRAPH . →

SCOTT BESSENT SURPRISE BOND BUYBACK SPARKS A SILVER RALLY . IS IT TOO LATE TO BUY IN ? →